AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

Joseph Hanley¹, Sean Dresser², William Simon³, Ryan Flynn⁴, Eric E Klein⁵, Daniel Letourneau⁶, Chihray Liu⁷, Fang-Fang Yin⁸, Bijan Arjomandy⁹, Lijun Ma¹⁰, Francisco Aguirre¹¹, Jimmy Jones¹², John Bayouth¹³, Todd Holmes¹⁴

Affiliations

¹ Princeton Radiation Oncology, Monroe, New Jersey, 08831, USA.
² Winship Cancer Institute, Radiation Oncology, Emory University, Atlanta, Georgia, 30322, USA.
³ Sun Nuclear Corp, Melbourne, Florida, 32940, USA.
⁴ Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, 52242, USA.
⁵ Brown university, Rhode Island Hospital, Providence, Rhode Island, 02905, USA.
⁶ Princess Margaret Cancer Centre, Toronto, M5G 2M9, Canada.
⁷ University of Florida, Gainesville, Florida, 32610-0385, USA.
⁸ Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, 27710, USA.
⁹ Karmanos Cancer Institute at McLaren-Flint, Flint, Michigan, 48532, USA.
¹⁰ Department of Radiation Oncology, University of California San Francisco, San Francisco, 94143-0226, USA.
¹¹ MD Anderson Cancer Center, Mansfield, OH, 44907, USA.
¹² Department of Radiation Oncology, The University of Colorado Health-Poudre Valley, Fort Collins, Colorado, 80525, USA.
¹³ Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, 53792-0600, USA.
¹⁴ Varian Medical Systems, Palo Alto, California, 94304, USA.

PMID: 34036590
DOI: 10.1002/mp.14992

AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

Joseph Hanley et al. Med Phys. 2021 Oct.

. 2021 Oct;48(10):e830-e885.

doi: 10.1002/mp.14992. Epub 2021 Aug 11.

Authors

Affiliations

¹ Princeton Radiation Oncology, Monroe, New Jersey, 08831, USA.
² Winship Cancer Institute, Radiation Oncology, Emory University, Atlanta, Georgia, 30322, USA.
³ Sun Nuclear Corp, Melbourne, Florida, 32940, USA.
⁴ Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, 52242, USA.
⁵ Brown university, Rhode Island Hospital, Providence, Rhode Island, 02905, USA.
⁶ Princess Margaret Cancer Centre, Toronto, M5G 2M9, Canada.
⁷ University of Florida, Gainesville, Florida, 32610-0385, USA.
⁸ Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina, 27710, USA.
⁹ Karmanos Cancer Institute at McLaren-Flint, Flint, Michigan, 48532, USA.
¹⁰ Department of Radiation Oncology, University of California San Francisco, San Francisco, 94143-0226, USA.
¹¹ MD Anderson Cancer Center, Mansfield, OH, 44907, USA.
¹² Department of Radiation Oncology, The University of Colorado Health-Poudre Valley, Fort Collins, Colorado, 80525, USA.
¹³ Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, 53792-0600, USA.
¹⁴ Varian Medical Systems, Palo Alto, California, 94304, USA.

PMID: 34036590
DOI: 10.1002/mp.14992

Abstract

The charges on this task group (TG) were as follows: (a) provide specific procedural guidelines for performing the tests recommended in TG 142; (b) provide estimate of the range of time, appropriate personnel, and qualifications necessary to complete the tests in TG 142; and (c) provide sample daily, weekly, monthly, or annual quality assurance (QA) forms. Many of the guidelines in this report are drawn from the literature and are included in the references. When literature was not available, specific test methods reflect the experiences of the TG members (e.g., a test method for door interlock is self-evident with no literature necessary). In other cases, the technology is so new that no literature for test methods was available. Given broad clinical adaptation of volumetric modulated arc therapy (VMAT), which is not a specific topic of TG 142, several tests and criteria specific to VMAT were added.

Keywords: QA; accelerator; quality assurance; radiotherapy.

PubMed Disclaimer

References

REFERENCES

1. Klein EE, Hanley J, Bayouth J, et al. Task Group 142 report: quality assurance of medical accelerators. Med Phys. 2009;36:4197.
1. Kutcher GJ, Coia L, Gillin M, et al. Comprehensive QA for radiation oncology: report of AAPM Radiation Therapy Committee Task Group 40. Med Phys. 1994;21:581-618.
1. Fought AM, Trager M, Yin FF, Kirkpatrick J, Adamson J. Re-examining TG-142 recommendations in light of modern techniques for linear accelerator based radiosurgery. Med Phys. 2016;43:5437.
1. Al-Hallaq HA, Chmura S, Salama JK, et al. Rationale of technical requirements for NRG-BR001: the first NCI-sponsored trial of SBRT for the treatment of multiple metastases. Pract radiat oncol. 2016;6:e291-e298.
1. Roper J, Chanyavanich V, Betzel G, Switchenko J, Dhabaan A. Single-isocenter multiple-target stereotactic radiosurgery: risk of compromised coverage. Int J Radiat Oncol Biol Phys. 2015;93:540-546.

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

Affiliations

AAPM Task Group 198 Report: An implementation guide for TG 142 quality assurance of medical accelerators

Authors

Affiliations

Abstract

References

REFERENCES

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous